Response to letter by Wang et al.: Comparing cardioprotection by remote ischaemic preconditioning in patients with and without diabetics.
E
E
Kottenberg
J
J
Peters
D048909:Diabetes Complications / Q000628:therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D019157:Ischemic Preconditioning, Myocardial / Q000379:methods*; D008297:Male; D009204:Myocardial Revascularization / Q000379:methods*; D013453:Sulfonylurea Compounds / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds